Journal
CURRENT RHEUMATOLOGY REPORTS
Volume 13, Issue 4, Pages 346-352Publisher
SPRINGER
DOI: 10.1007/s11926-011-0182-x
Keywords
Psoriatic arthritis; Psoriasis; Registries; Prognosis; Genetics; Biomarkers; Biologic therapy
Categories
Funding
- Canadian Institutes of Health Research/Clinical Research Initiative Fellowship
- Krembil Foundation
- CIHR-NET grant on psoriasis and psoriatic arthritis
Ask authors/readers for more resources
Psoriatic arthritis (PsA), an inflammatory musculoskeletal disease associated with psoriasis, is a complex disease in terms of its clinical presentation, etiology, and pathogenesis. Musculoskeletal presentations include peripheral arthritis, spondylitis, enthesitis, and dactylitis. To learn about the course of and prognosis for such a complex disease, it is important to observe patients longitudinally so that all aspects of the disease are recognized. Several registries have been developed to evaluate the course of and prognosis for patients with PsA. Based on such registries, it has been shown that PsA is more severe than previously thought, and that progression of joint damage is related to joint inflammation. Such registries also have been used to determine genetic factors in PsA and to identify biomarkers for both susceptibility and expression of the disease. Drug registries also have been developed to document response to new therapies as well as the long-term adverse effects resulting from such therapies. It is hoped that an international effort currently on the way will further enhance the contribution of PsA patient registries to address the etiology, pathogenesis, and outcome of this complex disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available